AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 223 filers reported holding AXSOME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,641,943 | -3.7% | 21,288 | -44.3% | 0.42% | -6.4% |
| Q3 2022 | $1,705,000 | +16.5% | 38,218 | 0.0% | 0.45% | +26.2% |
| Q2 2022 | $1,464,000 | -4.2% | 38,218 | +105.8% | 0.36% | -47.7% |
| Q2 2020 | $1,528,000 | -48.7% | 18,569 | -63.3% | 0.69% | -60.6% |
| Q1 2020 | $2,980,000 | -28.3% | 50,649 | +26.0% | 1.74% | +4.8% |
| Q4 2019 | $4,156,000 | +250.1% | 40,206 | -31.4% | 1.66% | +187.7% |
| Q3 2019 | $1,187,000 | -22.4% | 58,622 | -1.3% | 0.58% | -11.2% |
| Q2 2019 | $1,530,000 | +26.3% | 59,400 | -30.2% | 0.65% | +21.5% |
| Q1 2019 | $1,211,000 | – | 85,086 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |